Back to Top

Our People

Matthew Bainbridge, President and CEO 

Matthew has worked with high-throughput sequencing since its inception. At Canada's Michael Smith Genome Sciences Centre (BCGSC), he constructed the first algorithms for RNA seq, chip-seq, and structural rearrangement discovery for the 454 and Solexa sequencing platforms. He later received his PhD in structural and computational biology and molecular biophysics from his work at the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC). There he helped develop the BCM-HGSC’s illumina analysis pipeline, capture-resequencing analytics and co-developed capture reagents, both regional and whole exome including some of the largest capture targets ever sequenced. His analytic tools were central to the analysis of one the first personal genomes used for medical diagnostics[Lupski]. Later, he led the team that discovered the molecular cause of DRD in siblings. This information was used, for the first time, to alter the management and medications the children received. Later, he used WES to find a novel gene for  a previously undescribed disease, marking one of the first times WES was used to molecularly describe a disease prior to its clinical description. 

Eric Venner, Vice President, CTO 

Eric received his PhD in Structural and Computational Biology and Molecular Biophysics from the Baylor College of Medicine where he researched new approaches for predicting protein function and released several tools for use by the scientific community. Previously, he worked as a software developer, first creating custom software at Cimulus Inc. and later designing and implementing information systems for the University Information Technology Services department at Indiana University.

Board of Directors

Our board of directors consists of leaders in the clinical genomics and genetics field.